You are here

  • Home
  • Archive
  • Volume 30, Issue 6
  • Conflict of interest declarations in published healthcare reports and the need for supportive legislative frameworks: focus on hospital pharmacists' research activity worldwide

Article Text

Article menu
Download PDFPDF
PostScript
Letter
Conflict of interest declarations in published healthcare reports and the need for supportive legislative frameworks: focus on hospital pharmacists' research activity worldwide
  1. Andrea Zovi1,
  2. Fiorenzo Santoleri2,
  3. Ruggero Lasala3
  1. 1 Ministero della Salute, Roma, Lazio, Italy
  2. 2 Hospital Pharmacy, Pescara Hospital, Pescara, Abruzzo, Italy
  3. 3 Umberto I Corato Hospital, Corato, Italy
  1. Correspondence to Dr Andrea Zovi, Ministero della Salute, Roma, Lazio, Italy; zovi.andrea{at}gmail.com

https://doi.org/10.1136/ejhpharm-2022-003559

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Conflict of interest (COI) encompasses all those circumstances in which a secondary interest can potentially compromise professional actions concerning a primary interest.1 Healthcare is one of the sectors most at risk of generating COI. In clinical practice, the regulation of the declaration of conflict of interest (DCOI) for healthcare professionals (HCP) is not currently harmonised worldwide, although it is expected that DCOI will be included as a self-declaration in published papers.2 In fact, to improve transparency by conducting unbiased research and raising awareness among HCP, a number of guidelines have been disseminated in recent years by scientific associations such as the International …

    View Full Text

    Footnotes

    • Twitter @Ruggero Lasala

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; internally peer reviewed.